Hyperhidrosis Treatment Market Gains Momentum as Secondary Hyperhidrosis Grows Prevalent, Botulinum Toxin A Will be Sought-after

London, Dec. 27, 2022 (GLOBE NEWSWIRE) — An upcoming market intelligence study of Fairfield Market Research of global hyperhidrosis treatment market would comprise a multifaceted analysis of the current growth scenario of the market. The report intends to provide a thorough assessment of how the market will perform over the near term. Global hyperhidrosis treatment market has been progressing on the back of the consistently growing burden of primary hyperhidrosis that in turn generates demand for an effective treatment for the disease. The report however points to the fact that there has been a remarkable rise in the rate of prevalence of secondary hyperhidrosis over the past decade. This is expected to predominantly drive the growth of hyperhidrosis treatment market during the considered period of projection, i.e., 2022 – 2029.

Get the Sample Copy/TOC of Hyperhidrosis Treatment Market at: https://www.fairfieldmarketresearch.com/report/hyperhidrosis-treatment-market/request-toc

Insights into Segmental Analysis

In the wake of the rapid spread of sedentary modern lifestyle, unhealthy dietary patterns, and consequently rising prevalence of chronic health conditions like anxiety, hyperthyroidism, and hypoglycaemia, the cases of secondary generalized hyperhidrosis have been increasing faster against the number of cases of primary focal hyperhidrosis. The report thus primarily indicates dominance of primary hyperhidrosis segment by disease type but foresees higher market attractiveness for the secondary hyperhidrosis segment through 2029. On the other hand, based on the type of treatment, botulinum toxin A remains a prominent segment on the back of a more lasting impact, and higher effectiveness. Botulinum toxin type A injections remain a preferred non-invasive surgical procedure for primary focal hyperhidrosis and axillary hyperhidrosis treatment that lasts longer than topical treatments. It is often recommended for treating abnormally excessive sweating of hands and feet, in the armpits, face and head, as well as other areas of the body. Allergen Inc’s BOTOX has been the most researched and sought-after botulinum toxin across the world, marks the report.

Insights into Regional Analysis

On account of the consistently piling burden of primary hyperhidrosis, North America continues to lead its way in global hyperhidrosis treatment market. While the rate of diseases diagnosis here has been higher, the highly sophisticated healthcare system and infrastructure will remain instrumental to the build-up of hyperhidrosis treatment market in North America. The US spearheads, says the primary report findings, majorly banking on the widespread availability of public and private research funds. Around 3% of the population is currently living with hyperhidrosis in the US alone, pushing the consumption of an over-the-counter product aluminum chloride hexahydrate by 20% in 2021. The market here also leverages strong presence of some of the leading industry players. In addition to better awareness levels regarding safer medicine, the region will gain significantly from increasing emphasis on precision medicine. The US market is especially expected to benefit from accelerating pace of R&D activity eying effective hyperhidrosis treatment. Several innovative products continue to debut the hyperhidrosis treatment market space in the US, which will remain among the strong push factors for the expansion of market here. For instance, a research experiment on the effectiveness of a topical product (2019) affirmed reduced severity of sweating, sweat production, and sweat toleration. Key companies like Dermira, Inc. frequently introduce innovative hyperhidrosis treatment products for both pediatric and adult patients, thereby supporting market growth. R&D continues to flourish and will play a vital role in boosting the value growth of hyperhidrosis treatment market of North America.

Key Competitors in Global Hyperhidrosis Treatment Market

GlaxoSmithKline plc, Sientra, Inc., Dermira, Inc, AbbVie, Inc., Ulthera, Inc., Allergan, Inc., Revance Therapeutics, Inc., Brickell Biotech, Inc., TheraVida, Inc., and Brickell Biotech, Inc. are some of the significant players steering the competition landscape of global hyperhidrosis treatment market. The report would shed light on the strategic competitive profiling and analysis of industry leaders.

Do You Have Any Query or Specific Requirement? Request for Custom Research: https://www.fairfieldmarketresearch.com/report/hyperhidrosis-treatment-market/request-customization

Global Hyperhidrosis Treatment Market is Segmented as Below:

By Treatment Type

  • Botulinum Toxin A
  • Laser Treatments
  • Surgical Treatments
  • Topical Treatments
  • Others

By Disease Type

  • Primary Focal Hyperhidrosis
  • Secondary Generalised Hyperhidrosis

By End-user

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Japan
    • South Korea
    • India
    • China
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East
    • Africa

Report Inclusions

  • Market Estimates and Forecast
  • Market Dynamics
  • Industry Trends
  • Competition Landscape
  • Treatment Type-wise Analysis
  • Disease-wise Analysis
  • End User-wise Analysis
  • Region-wise Analysis
  • Country-wise Analysis
  • Key Trends Analysis
  • COVID-19 Impact Analysis

About Us

Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.

Contact

Fairfield Market Research
London, UK
UK +44 (0)20 30025888   
USA (Toll-free) +1 (844) 3829746 
Web: https://www.fairfieldmarketresearch.com/
Email: [email protected]

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Mango Bunch takes no editorial responsibility for the same.